Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
11%(1 trials)

Phase Distribution

Ph phase_3
1
9%
Ph phase_4
1
9%
Ph not_applicable
9
82%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(9)
Other(1)

Detailed Status

Completed9
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (9.1%)
Phase 41 (9.1%)
N/A9 (81.8%)

Trials by Status

completed982%
not_yet_recruiting19%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11